Efficacy and safety of Koff-N-Cold tablets in patients with allergic rhinitis or seasonal cough and cold: a prospective, randomized, open label, two-arm clinical trial

Tahira H. S.; Gangothri S. Kumar; Ashok Godavarthi; Suda Amarnath Reddy

doi:10.18203/2319-2003.ijbcp20263781

Authors

Tahira H. S. Department of Research and Development, Greenspace, Bengaluru, Karnataka, India
Gangothri S. Kumar Department of Research and Development, Greenspace, Bengaluru, Karnataka, India
Ashok Godavarthi Radiant Research Services Pvt. Ltd. Bengaluru, Karnataka, India
Suda Amarnath Reddy Department of General Medicine, Sri Venkateshwara Hospital, Bengaluru, Karnataka, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20263781

Keywords:

Allergic rhinitis, Seasonal cough and cold, Herbal medicine, Randomized clinical trial, Immunoglobulin E, C-reactive protein, Safety and efficacy

Abstract

Background: Koff-N-Cold is a proprietary polyherbal formulation developed to target both allergic and anti-inflammatory conditions. The objective of this study is to evaluate the efficacy and safety of Koff-N-Cold tablets compared with standard antihistamine therapy in adults with allergic rhinitis or seasonal cough and cold.

Methods: This study is a prospective, randomized, open-label, two-arm clinical trial. Sixty adult subjects (18-65 years) with allergic rhinitis or seasonal cough and cold were randomized in a 1:1 ratio to receive standard therapy [combination of levocetirizine (5 mg) and phenylephrine (5 mg)] for 5 days and Koff-N-Cold tablets for up to 10 days. Efficacy was assessed using symptom severity questionnaires and allergen-specific and anti-inflammatory biomarkers such as serum immunoglobulin E (IgE) and C-reactive protein (CRP) at baseline and Day 10. Safety was evaluated through adverse event monitoring, vital signs, and hematological parameters.

Results: Both treatment groups showed significant improvement in symptom scores from baseline to Day 10. The Koff-N-Cold group showed marked reduction in total symptom scores, serum IgE, and CRP levels by Day 10, therefore achieving improvements greater than the standard levocetirizine and phenylephrine. No adverse events or clinically significant laboratory abnormalities were reported in either group.

Conclusions: Koff-N-Cold tablets were safe and effective in reducing symptoms and inflammatory markers associated with allergic rhinitis and seasonal cough and cold. The findings support Koff-N-Cold as a well-tolerated, evidence-based herbal alternative to conventional antihistamine therapy.

Trial registration: Trial registration number: CTRI/2025/07/092048

References

Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63(86):160.

Pawankar R, Canonica GW, Holgate ST, Lockey RF. World Allergy Organization White Book on Allergy. World Allergy Organization. 2013.

Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111(12):1805-12.

Simons FE, Simons KJ. Histamine and H1-antihistamines: celebrating a century of progress. J Allergy Clin Immunol. 2011;128(6):1139-50.

Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report. 2008;12:1-23.

Mondal S, Varma S, Bamola VD, Naik SN, Mirdha BR, Padhi MM, et al. Double-blinded randomized controlled trial for immunomodulatory effects of Tulsi (Ocimum sanctum Linn.) leaf extract on healthy volunteers. J Ethnopharmacol. 2011;136(3):452-6.

Dhuley JN. Antitussive effect of Adhatoda vasica extract on mechanical or chemical stimulation-induced coughing in animals. J Ethnopharmacol. 1999;67(3):361-5.

Nath V, Buragohain P, Sharma H. A Review of some medicinal plants of Northeast India used in the treatment of respiratory disorders. Curr Trends Pharm Res. 2021;8:158-91.

Hewlings SJ, Kalman DS. Curcumin: A Review of Its Effects on Human Health. Foods. 2017;6(10):92.

Friedman LM, Furberg CD, DeMets DL, Reboussin DM, Granger CB. Fundamentals of Clinical Trials. 5th

ed. Springer. 2015.

Gould HJ, Sutton BJ. IgE in allergy and asthma today. Nat Rev Immunol. 2008;8(3):205-17.

Kiran M, Shah MP, George MS, Pawaskar ML. Efficacy and Safety of a Combination of Levocetirizine and Phenylephrine in the Treatment of Allergic Rhinitis and Eustachian Tube Dysfunction. Int J Innovat Res Med Sci. 2017;2:815-9.

Snidvongs K, Seresirikachorn K, Khattiyawittayakun L, Chitsuthipakorn W. Sedative effects of levocetirizine: a systematic review and meta-analysis of randomized controlled studies. Drugs. 2017;77:175-86.

Hu W, Li H, Zeng L, Gan J, Feng C, Chen L, et al. Data mining in FAERS: association of newer generation H1-antihistamines with nervous system disorders. BMC Pharmacol Toxicol. 2024;25:95.

Small P, Keith PK, Kim H. Allergic rhinitis. Allergy Asthma Clin Immunol. 2018;14:51.

Dinesh B, Tahira HS. The potential pharmacological mechanism of medicinal herbs for the treatment of cough and cold via network pharmacology, molecular docking, and simulation. Eur J Med Health Sci. 2025;7(6):13-36.

Li H, Kreiner JM, Wong AR, Li M, Sun Y, Lu L, et al. Oral application of Chinese herbal medicine for allergic rhinitis: A systematic review and meta-analysis of randomized controlled trials. Phytother Res. 2021;35(6):3113-29.

Guo R, Pittler MH, Ernst E. Herbal medicines for the treatment of allergic rhinitis: a systematic review. Ann Allergy Asthma Immunol. 2007;99(6):483-95.

Rahim NA, Jantan I, Said MM, Jalil J, Abd Razak AF, Husain K. Anti-Allergic Rhinitis Effects of Medicinal Plants and Their Bioactive Metabolites via Suppression of the Immune System: A Mechanistic Review. Front Pharmacol. 2021;12:660083.